Susquehanna International Group, LLP Athenex, Inc. Call Options Transaction History

Susquehanna International Group, LLP

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$1.36 - $2.94 $153,000 - $330,750	-112,500 Reduced 75.35%	36,800 $50,000
Q3 2021 Nov 15, 2021	SELL	$2.97 - $4.84 $62,667 - $102,124	-21,100 Reduced 12.38%	149,300 $449,000
Q2 2021 Aug 11, 2021	SELL	$3.71 - $5.13 $244,860 - $338,580	-66,000 Reduced 27.92%	170,400 $787,000
Q1 2021 May 17, 2021	BUY	$4.08 - $14.75 $447,168 - $1.62 Million	109,600 Added 86.44%	236,400 $1.02 Million
Q4 2020 Feb 16, 2021	BUY	$11.06 - $14.01 $548,576 - $694,896	49,600 Added 64.25%	126,800 $1.4 Million
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $153,900 - $218,250	15,000 Added 24.12%	77,200 $934,000
Q2 2020 Aug 14, 2020	SELL	$7.11 - $13.76 $703,890 - $1.36 Million	-99,000 Reduced 61.41%	62,200 $856,000
Q1 2020 May 15, 2020	BUY	$5.71 - $15.85 $34,260 - $95,100	6,000 Added 3.87%	161,200 $1.25 Million
Q4 2019 Feb 14, 2020	SELL	$9.6 - $17.75 $97,920 - $181,050	-10,200 Reduced 6.17%	155,200 $2.37 Million
Q3 2019 Nov 14, 2019	SELL	$12.16 - $21.0 $1.48 Million - $2.56 Million	-122,000 Reduced 42.45%	165,400 $2.01 Million
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $1.96 Million - $4.1 Million	207,200 Added 258.35%	287,400 $5.69 Million
Q1 2019 May 15, 2019	BUY	$11.11 - $13.49 $517,726 - $628,634	46,600 Added 138.69%	80,200 $982,000
Q4 2018 Feb 14, 2019	BUY	$10.24 - $15.49 $100,352 - $151,802	9,800 Added 41.18%	33,600 $426,000
Q3 2018 Nov 14, 2018	BUY	$15.53 - $19.97 $369,614 - $475,286	23,800 New	23,800 $370,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.